Slightly photo-crosslinked chitosan/silk fibroin hydrogel adhesives with hemostasis and anti-inflammation for pro-healing cyclophosphamide-induced hemorrhagic cystitis.

Authors:
Yao J; Chen Y; Zhang X; Chen J; Zhou C and 3 more

Journal:
Mater Today Bio

Publication Year: 2024

DOI:
10.1016/j.mtbio.2024.100947

PMCID:
PMC10826334

PMID:
38298562

Journal Information

Journal Title: Mater Today Bio

Detailed journal information not available.

Publication Details

Subject Category: Materials Science, Biomaterials

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Junhui Jiang reports financial support was provided by Ningbo Clinical Research Center for Urological Disease. Hua Zhang reports financial support was provided by Open Foundation of the 10.13039/501100011310State Key Laboratory of Fluid Power and Mechatronic Systems. Hua Zhang reports financial support was provided by Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province. Cheng Zhou reports financial support was provided by Zhejiang Natural Science Fund. Jie Yao reports financial support was provided by 10.13039/501100007928Ningbo Science and Technology Bureau. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"This study is supported by the Ningbo Top Medical and 10.13039/100005622Health Research Program (2022020203), Ningbo Clinical Research Center for Urological Disease (2019A21001), Open Foundation of the 10.13039/501100011310State Key Laboratory of Fluid Power and Mechatronic Systems (GZKF-202119), Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province (2022E10026), Zhejiang Natural Science Fund (LTGY23H050002) and the Natural Science Foundation of Ningbo City (2023J159, 2022J121). We thank Dr. Suying Wang of the Ningbo Clinical Pathology Diagnosis Center for interpretation and guidance of immunohistochemical pathology section results. Special thanks to the technical support by the Core Facilities and Laboratory Animal Center, Health Science Center of Ningbo University. Jie Yao: Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing. Yaoqi Chen: Data curation, Formal analysis, Investigation, Methodology. Xiang Zhang: Formal analysis, Investigation, Methodology. Junfeng Chen: Conceptualization, Funding acquisition, Validation. Cheng Zhou: Funding acquisition, Investigation, Validation. Junhui Jiang: Funding acquisition, Investigation, Project administration. Hua Zhang: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Supervision, Writing – review & editing. Kerong Wu: Funding acquisition, Investigation, Project administration, Supervision, Writing – review & editing. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Junhui Jiang reports financial support was provided by Ningbo Clinical Research Center for Urological Disease. Hua Zhang reports financial support was provided by Open Foundation of the 10.13039/501100011310State Key Laboratory of Fluid Power and Mechatronic Systems. Hua Zhang reports financial support was provided by Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province. Cheng Zhou reports financial support was provided by Zhejiang Natural Science Fund. Jie Yao reports financial support was provided by 10.13039/501100007928Ningbo Science and Technology Bureau. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025